Datye Karishma A, Tilden Daniel R, Parmar Angelee M, Goethals Eveline R, Jaser Sarah S
Ian M. Burr Division of Pediatric Endocrinology and Diabetes, Department of Pediatrics, Vanderbilt University Medical Center, 1500 21st Ave. South Suite 1514, Nashville, TN, 37212-3157, USA.
Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Curr Diab Rep. 2021 May 15;21(7):22. doi: 10.1007/s11892-021-01389-1.
Continuous glucose monitors (CGM) are transforming diabetes management, yet adolescents and young adults (AYA) with type 1 diabetes (T1D) do not experience the same benefits seen with CGM use in adults. The purpose of this review is to explore advances, challenges, and the financial impact of CGM use in AYA with T1D.
CGM studies in young adults highlight challenges and suggest unique barriers to CGM use in this population. Recent studies also demonstrate differences in CGM use related to race and ethnicity, raising questions about potential bias and emphasizing the importance of patient-provider communication. Cost of these devices remains a significant barrier, especially in countries without nationalized reimbursement of CGM. More research is needed to understand and address the differences in CGM utilization and to increase the accessibility of CGM therapy given the significant potential benefits of CGM in this high-risk group.
持续葡萄糖监测仪（CGM）正在改变糖尿病管理方式，但1型糖尿病（T1D）青少年和青年（AYA）并未像成年人使用CGM那样获得相同的益处。本综述旨在探讨CGM在T1D的AYA群体中的应用进展、挑战及经济影响。
针对青年成年人的CGM研究凸显了挑战，并表明该群体使用CGM存在独特障碍。近期研究还表明，CGM的使用在种族和民族方面存在差异，引发了对潜在偏差的质疑，并强调了医患沟通的重要性。这些设备的成本仍是一个重大障碍，尤其是在没有CGM国家报销政策的国家。鉴于CGM对这一高风险群体具有显著潜在益处，需要开展更多研究以了解和解决CGM使用方面的差异，并提高CGM治疗的可及性。
